1172.1 - Testing for BRAF mutation in patients with metastatic melanoma for access to vemurafenib (resubmission)

Page last updated: 16 June 2016

Application Detail

Status

Closed

Description of Medical Service

Testing for BRAF mutation is to identify in tumours obtained from metastatic melanoma patients those that carry the BRAF V600 mutation.

Description of Medical Condition

Patients with unresectable or metastatic (stage IIIC or stage IV) melanoma

Reason for Application

New MBS item

Medical Service Type

Co-dependent technology

Previous Application Number

1172

Associated Documentation

Application Form

-

PICO Confirmation

As per application 1172

Assessment Report

As per application 1172

Public Summary Document

Public Summary Document (PDF 124 KB)
Public Summary Document (Word 64 KB)

Meetings for this Application

PASC

-

ESC

-

MSAC

31 March 2016